North America Diabetes Care Devices Market (2025-2030)
The North America Diabetes Care Devices Market was valued at $12964.7 Million in 2025 and projected to reach to $22883.8 Million by 2030, representing a compound annual growth rate of 12.0%. North America's diabetes care devices market is poised for sustained expansion through 2030, driven by the region's aging population, rising obesity rates, and increasing diabetes incidence.
| Market Size in | USD 26.32 MN |
| Market Forecast in | |
| CAGR | |
| Forecast Period | |
| Units Considered | Value (USD MN) |
North America Diabetes Care Devices Market Trends and Insights
- This 12.0% compound annual growth rate reflects North America's strong healthcare infrastructure, high prevalence of diabetes, and increasing adoption of advanced monitoring and insulin delivery technologies.
- North America leads globally in innovation and patient access to cutting-edge diabetes management solutions. The North America market is driven by rising diabetes incidence, aging populations, and growing consumer demand for connected health devices.
- North America's regulatory environment and reimbursement landscape support rapid commercialization of new technologies, including continuous glucose monitors, insulin pumps, and digital health platforms.
- By 2030, North America is expected to maintain its position as a key revenue generator, with sustained investment in diabetes care innovation and patient-centric solutions..
Key Market Statistics
- CAGR (2025-2030) 12.0% CAGR
- Market Size, 2025 ~USD 12964.7 Million
- Forecast, 2030 ~USD 22883.8 Million
- Geography North America
North America Diabetes Care Devices Market Overview
Market Leadership Position :
North America commands the largest share of the global diabetes care devices market, with the US alone representing $21.3 billion of the $12.96 billion regional total in 2025, driven by advanced healthcare infrastructure and high device adoption rates.
Accelerated Growth Trajectory :
The region is projected to grow from $12.96 billion in 2025 to $22.88 billion by 2030 at a 12.0% CAGR, outpacing many global markets due to increasing diabetes prevalence and technological innovation in continuous glucose monitoring and insulin delivery systems.
Technology Adoption Leadership :
North America leads in adoption of advanced diabetes management technologies, including connected devices, artificial intelligence-enabled monitoring systems, and integrated digital health platforms that enhance patient outcomes and engagement.
Reimbursement and Regulatory Support :
Favorable reimbursement policies from Medicare, Medicaid, and private insurers in the US and Canada, combined with streamlined FDA approval pathways, accelerate market penetration of innovative diabetes care devices across the region.
North America Diabetes Care Devices Market Dynamics
- The market benefits from robust healthcare spending, strong insurance coverage, and early adoption of cutting-edge technologies such as automated insulin delivery systems and real-time glucose monitoring devices.
- Healthcare providers and patients in the US and Canada increasingly prioritize precision medicine and personalized diabetes management solutions. Key growth catalysts include ongoing product innovation, integration of artificial intelligence and cloud-based analytics, and expanding reimbursement coverage for remote monitoring devices.
- Strategic partnerships between device manufacturers and healthcare systems, coupled with growing patient awareness and digital health adoption, will further accelerate market growth.
- North America's regulatory environment continues to support rapid commercialization of breakthrough technologies, positioning the region as a global innovation hub for diabetes care solutions..
Related Ecosystem
Medical Devices
- Polymerase Chain Reaction (PCR)
- Magnetic Resonance Imaging (MRI)
- Disposable Autoinjectors
- Pulse Oximeters
- Blood Pressure Monitors
- Medtronic plc
- Abbott Laboratories
- Stryker Corporation
- Becton, Dickinson and Company
- JOHNSON & JOHNSON
Key Takeaways
- North America's diabetes care devices market will grow from $12,964.7M (2025) to $22,883.8M (2030) at a 12.0% CAGR.
- North America's advanced healthcare infrastructure and high reimbursement rates accelerate adoption of innovative diabetes management technologies.
- North America's rising diabetes prevalence and aging population drive sustained demand for continuous glucose monitors and insulin delivery systems.
- North America's regulatory framework and digital health integration position the region as a leader in next-generation diabetes care solutions.
Diabetes Care Devices Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | DIABETES MANAGEMENT MOBILE APPLICATIONS (Product Type) |
| Forecast Period | 2025-2030 |
| Growth Rate | CAGR of 12.3% from 2025 to 2030 |
| Largest Segment | TYPE 2 DIABETES (Disease Type) |
| Market Size Base Year (Billions) | ~USD 34.27 (2025) |
| Revenue Forecast (Billions) | ~USD 61.2 (2030) |
| Segments Covered | Product Type, Type, Disease Type, Patient Care Settings |
North America Diabetes Care Devices Market Report Segmentation
4 segment dimensions are covered across the global market.
By Product Type
- Blood Glucose Monitoring System
- Blood Glucose Monitoring Systems
- Diabetes Management Mobile Applications
- Insulin Delivery Devices
By Type
- Continuous Glucose Monitoring Systems
- Disposable Insulin Pens
- Insulin Pens
- Insulin Pumps & Accessories
- Insulin Syringes & Needles
- Lancets/Lancing Devices
- Other Insulin Delivery Devices
- Pen Needles
- Reusable Insulin Pens
- Self-Monitoring Blood Glucose Systems
- Test Strips/ Test Papers
- Test Strips/Test Papers
- Tethered Insulin Pumps
- Tubeless Insulin Pumps
By Disease Type
- Type 1 Diabetes
- Type 2 Diabetes
By Patient Care Settings
- Hospitals & Diabetes Specialty Clinics
- Self/ Home Healthcare
- Self/Home Healthcare
Target Audience
- Medical Device Manufacturers : Device companies need North America-specific market data to benchmark competitive positioning, identify market gaps, and develop targeted go-to-market strategies in the region's high-value diabetes care segment.
- Healthcare Investors & PE Firms : Investment professionals require detailed North American market forecasts and country-level valuations to evaluate acquisition targets, assess portfolio company growth potential, and identify emerging opportunities in diabetes care innovation.
- Healthcare Providers & Hospital Systems : Hospital networks and clinics need market intelligence on device adoption trends, reimbursement policies, and technology innovations to optimize procurement decisions and enhance patient care delivery across North America.
- Pharmaceutical & Biotech Companies : Pharma companies expanding into diabetes care devices require North American market insights to identify partnership opportunities, assess competitive threats, and develop integrated treatment solutions for regional markets.
- Market Research & Consulting Firms : Research organizations need comprehensive North America diabetes devices data to support client advisory services, validate market assumptions, and provide evidence-based strategic recommendations to healthcare stakeholders.
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 21321.2 Million |
| Canada | USD 1562.6 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Validation : Access precise market valuations for North America ($12.96B in 2025) and country-level breakdowns for the US and Canada, enabling accurate financial forecasting and investment decision-making for the region's fastest-growing healthcare segment.
- Competitive Landscape Intelligence : Understand market dynamics specific to North America, including key players, market consolidation trends, and competitive positioning in the world's largest diabetes devices market, critical for strategic planning and market entry strategies.
- Technology Adoption Insights : Gain detailed analysis of North American adoption patterns for advanced technologies including CGM systems, automated insulin delivery, and digital health integration, helping identify high-growth product categories and innovation opportunities.
- Regulatory & Reimbursement Guidance : Leverage region-specific insights on FDA approval pathways, Medicare/Medicaid coverage policies, and insurance reimbursement trends that directly impact market access and commercial success in North America.
- Strategic Market Expansion : Identify growth opportunities across North American markets with country-specific data on diabetes prevalence, healthcare infrastructure, and device penetration rates to optimize market entry and expansion strategies.
Frequently asked questions
What is the projected market size for diabetes care devices in North America by 2030?
North America's diabetes care devices market is projected to reach $22,883.8 million by 2030, growing from $12,964.7 million in 2025.
What is the CAGR for North America's diabetes care devices market?
North America's diabetes care devices market is expected to grow at a compound annual growth rate of 12.0% between 2025 and 2030.
What factors are driving growth in North America's diabetes care devices market?
North America's market growth is driven by rising diabetes prevalence, aging populations, advanced healthcare infrastructure, strong reimbursement policies, and increasing adoption of connected health technologies.
Which diabetes care devices are most popular in North America?
North America shows strong demand for continuous glucose monitors, insulin pumps, digital health platforms, and integrated diabetes management systems that offer real-time monitoring and data connectivity.
How does North America's market compare to global diabetes care devices growth?
North America's 12.0% CAGR is slightly below the global 12.3% CAGR, but North America maintains the largest absolute market value and leads in innovation and technology adoption.
RESEARCH METHODOLOGY
The study involved four main activities to estimate the current size of the diabetes care devices market. First, extensive secondary research was conducted to gather information about the market, including related and parent markets. The next step was validating these findings, assumptions, and market size estimates through primary research with industry experts across the value chain. Both top-down and bottom-up methods were used to develop a comprehensive estimate of the overall market size. Lastly, market segmentation and data triangulation techniques were employed to determine the sizes of segments and subsegments within the market.
Secondary Research
The secondary research process involved extensive use of various sources, including directories, databases like Bloomberg Business, Factiva, and D&B Hoovers, as well as white papers, annual reports, company house documents, investor presentations, and SEC filings. This research was conducted to gather information valuable for a comprehensive, technical, market-oriented, and commercial study of the diabetes care devices market. It also helped obtain critical insights about key industry players, market classification, and segmentation based on current industry trends, down to the finest details. Additionally, a database of leading industry players was created through this secondary research.
Primary Research
In the primary research process, we conducted interviews with various sources from both the supply and demand sides to gather qualitative and quantitative information for this report. On the supply side, industry experts, including CEOs, vice presidents, marketing and sales directors, technology and innovation directors, and other key executives from prominent companies and organizations involved in the diabetes care devices market, were interviewed. For the demand side, engagement with industry experts, purchase and sales managers, doctors, and personnel from research organizations was done. This primary research was essential to validate market segmentation, identify key players in the industry, and gather insights on important industry trends and market dynamics.
A breakdown of the primary respondents for the diabetes care devices market is provided below:
Note 1: C-level executives include CEOs, COOs, CTOs, and VPs.
Note 2: Others include sales, marketing, and product managers.
Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1=>USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = < USD 500 million.
To know about the assumptions considered for the study, download the pdf brochure
Market Size Estimation
The research methodology used to estimate the size of the diabetes care devices market includes the following details.
The market sizing was undertaken from the global side.
Country-level Analysis: The size of the diabetes care devices market was determined from annual presentations by leading companies and publicly available secondary data. The share of products and services within the overall diabetes care devices market was calculated using secondary data and verified by primary participants to arrive at the total market size. Primary participants also further validated the data numbers.
Geographic Market Assessment (By Region & Country): The geographic assessment was done using the following approaches:
Approach 1: Geographic revenue contributions/splits of leading players in the market (wherever available) and respective growth trends
Approach 2: Geographic adoption trends for individual product segments by end users and growth prospects for each of the segments (assumptions and indicative estimates validated from primary interviews)
At each stage, the assumptions and approaches were verified with industry experts contacted during primary research. Due to limitations in the data from secondary research, revenue estimates for individual companies (covering the overall diabetes care devices market and geographic market assessment) were determined based on a detailed analysis of their product offerings, geographic reach or strength (whether direct or through distributors or suppliers), and the market shares of leading players in specific regions and countries.
Global Diabetes Care Devices Market Size: Bottom-up and Top-down Approach
Data Triangulation
After determining the overall size from the market size estimation process described above, the total market was divided into several segments and subsegments. The data triangulation and market breakdown procedures outlined below were applied, where appropriate, to complete the overall market analysis and obtain precise statistics for various segments. The data was triangulated by examining different factors and trends from both demand and supply perspectives. Additionally, the market size was validated using both the top-down and bottom-up approaches.
Market Definition
The diabetes care devices includes medical technologies and tools used for monitoring, managing, and treating diabetes. It features blood glucose monitoring systems (such as glucometers, continuous glucose monitors, test strips, and lancets), insulin delivery devices (including insulin pens, pumps, syringes, and automated delivery systems), and related accessories. These devices help track glucose accurately, deliver insulin effectively, and improve patient outcomes by enabling better disease control, reducing complications, and enhancing quality of life. The market serves patients, healthcare providers, and caregivers and is driven by technological innovations, the rising prevalence of diabetes, and increasing demand for connected, user-friendly solutions.
Stakeholders
- Diabetes Care Devices’ Manufacturing Companies
- Contract Manufacturers
- Distributors, Suppliers, and Channel Partners of Diabetes Care Devices
- Senior Management
- Finance Department
- Procurement Department
- Hospitals & Clinics
- E-commerce and Digital Platforms
- Retail Pharmacies and Supermarkets
- Academic & Research Institutes
- Trade Associations and Industry Bodies
- Regulatory Bodies and Government Agencies
- Business Research and Consulting Service Providers
- Market Research and Consulting Firms
- Venture Capitalists and Investors
Report Objectives
- To define, describe, segment, analyse, and forecast the global diabetes care devices market by product type, disease type, patient care settings, and region
- To provide detailed information about the factors influencing market growth (drivers, restraints, opportunities, and challenges)
- To analyze micro markets concerning individual growth trends, prospects, and contributions to the overall market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the diabetes care devices market in North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC countries
- To profile the key players in the diabetes care devices market and comprehensively analyze their core competencies
- To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the diabetes care devices market
Get the Full Diabetes Care Devices Market Report
Full forecast, segment splits, and company analysis for all Diabetes Care Devices Market.
- Canada Diabetes Care Devices Market
- US Diabetes Care Devices Market
- Germany Diabetes Care Devices Market
- UK Diabetes Care Devices Market
- France Diabetes Care Devices Market
- Italy Diabetes Care Devices Market
- Spain Diabetes Care Devices Market
- China Diabetes Care Devices Market
- Japan Diabetes Care Devices Market
- India Diabetes Care Devices Market
- Australia Diabetes Care Devices Market
- South Korea Diabetes Care Devices Market
- Brazil Diabetes Care Devices Market
- Mexico Diabetes Care Devices Market
- GCC Countries Diabetes Care Devices Market
- Rest Of Europe Diabetes Care Devices Market
- Rest Of Asia Pacific Diabetes Care Devices Market
- Rest Of Latin America Diabetes Care Devices Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report
